Morbidity and Mortality Weekly Report: MMWRU.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, 1996 |
Inni boken
Resultat 1-5 av 19
Side 469
... doses , ZDV PEP usually is tolerated well by health - care workers ; short - term toxicity associated with higher doses primarily includes gastro- intestinal symptoms , fatigue , and headache ( 3,7 ) . The toxicity of other ...
... doses , ZDV PEP usually is tolerated well by health - care workers ; short - term toxicity associated with higher doses primarily includes gastro- intestinal symptoms , fatigue , and headache ( 3,7 ) . The toxicity of other ...
Side 493
... doses for the eye . In the United States , although the proportion of hospitals that produce their own ophthalmic solutions is unknown , most ophthalmic solutions used intraoperatively probably are commercially prepared . However , in ...
... doses for the eye . In the United States , although the proportion of hospitals that produce their own ophthalmic solutions is unknown , most ophthalmic solutions used intraoperatively probably are commercially prepared . However , in ...
Side 508
... doses of four specific vaccines . All households identified in the first and second quarters of 1995 were in- cluded in the second phase . Based on exclusions , 30,543 ( 86 % ) children were eligible for the second phase ; of these ...
... doses of four specific vaccines . All households identified in the first and second quarters of 1995 were in- cluded in the second phase . Based on exclusions , 30,543 ( 86 % ) children were eligible for the second phase ; of these ...
Side 509
... doses of DTP , three doses of poliovirus vaccine , and one dose of MMR ) and 4 : 3 : 1 : 3 ( i.e. , four doses of DTP , three doses of poliovirus vaccine , one dose of MMR , and three doses of Hib ) remained stable . For every vaccine ...
... doses of DTP , three doses of poliovirus vaccine , and one dose of MMR ) and 4 : 3 : 1 : 3 ( i.e. , four doses of DTP , three doses of poliovirus vaccine , one dose of MMR , and three doses of Hib ) remained stable . For every vaccine ...
Side 510
... doses of diphtheria and tetanus toxoids and pertussis vaccine / diphtheria and tetanus toxoids ( DTP / DT ) , three doses of poliovirus vaccine , and one dose of measles - mumps - rubella vaccine ( MMR ) . * Four doses of DTP / DT ...
... doses of diphtheria and tetanus toxoids and pertussis vaccine / diphtheria and tetanus toxoids ( DTP / DT ) , three doses of poliovirus vaccine , and one dose of measles - mumps - rubella vaccine ( MMR ) . * Four doses of DTP / DT ...
Vanlige uttrykk og setninger
4-week totals Alaska Ariz associated ATLANTIC blastomycosis Calif CDC's Center for Infectious Centers for Disease clinical Colo Congenital rubella syndrome Conn contaminated Control and Prevention Cryptosporidiosis death Department of Health Dept diphtheria Disease Control doses Drug Editorial Note endophthalmitis ephedrine Epidemiology Escherichia coli exposure Guam Hawaii Hepatitis HIV infection hobo spider hospital Idaho identified Immunization increased infants Infectious Diseases injuries July Kans Laboratory Legionellosis lowa Lyme Disease Maine N.H. Malaria Mass measles Minn MMWR Series MMWR weekly N.Y. City National Center Nebr number of reported Ohio Okla onset Oreg outbreak PACIFIC patients Pertussis polio Poliomyelitis poliovirus Program Public Health Service Rabies Reporting Area 1996 risk Rubella Samoa C.N.M.I. scopolamine selected notifiable diseases smallpox surveillance TABLE Tenn testing tetanus United Updated Upstate N.Y. Utah vaccine W.S. CENTRAL Wash weeks ending June women
Populære avsnitt
Side 672 - Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia. West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming.
Side 471 - O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy JF, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment.
Side 608 - Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Hampshire, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Vermont, Virginia, West Virginia, and Wisconsin— OME, Room, 2B, Post Office Building, Knoxville 2, Tennessee.
Side 610 - Blood lead levels in the US population. Phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991).
Side 530 - No health department, State or local, can effectively prevent or control disease without knowledge of when, where, and under what conditions cases are occurring.
Side 568 - Income in 1989.") Poverty statistics presented in census publications were based on a definition originated by the Social Security Administration in 1964 and subsequently modified by Federal interagency committees in 1969 and 1980 and prescribed by the Office of Management and Budget in Directive 14 as the standard to be used by Federal agencies for statistical purposes. At the core of this definition was the...
Side 464 - ... which involve one or more of the following: loss of consciousness, restriction of work or motion, transfer to another job, or medical treatment (other than first aid).
Side 670 - Recommendations of the US Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.
Side 471 - Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood — France, United Kingdom, and United States, January 1988-August 1994.
Side 512 - The budget also funds full participation in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), which will provide benefits to 7.5 million people by the end of 1999.